Cargando…
The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
Alzheimer’s disease (AD) is a global health problem, with incidence and prevalence considered to increase during the next decades. However, no currently available effective treatment exists despite numerous clinical trials in progress. Moreover, although many hypotheses are accepted regarding the pa...
Autores principales: | Schreiner, Thomas Gabriel, Menéndez-González, Manuel, Popescu, Bogdan Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313192/ https://www.ncbi.nlm.nih.gov/pubmed/35884814 http://dx.doi.org/10.3390/biomedicines10071509 |
Ejemplares similares
-
Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2021) -
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
A Nanostructured Protein Filtration Device for Possible Use in the Treatment of Alzheimer’s Disease—Concept and Feasibility after In Vivo Tests
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2023) -
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)